Clinical trial
Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer
NCT00006486 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00006486 |
|---|---|
| Title | Carboxyamidotriazole in Treating Patients With Metastatic Kidney Cancer |
| Official title | A Phase II Randomized Discontinuation Trial Of Carboxyaminoimidazole (CAI, NSC 609974) In Metastatic Renal Carcinoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer |
| Intervention type | Drug, Other |
| Interventions | carboxyamidotriazole, placebo |
| Enrollment | 335 |
| Start date | Oct 1, 2000 |
| Primary completion | Oct 1, 2005 |
| First posted | Jul 28, 2003 |
| Last update posted | Jan 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: